Get startedLog in
    Picture of Cumberland Pharmaceuticals logo

    CPIX — Cumberland Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Cumberland Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:10-K10-K10-K10-K10-K
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-3.6-5.65-6.33-6.44-2.86
    Depreciation
    Deferred Taxes
    Non-Cash Items-2.84-1.672.85-0.3641.49
    Discontinued Operations
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital8.1810.44.631.292.16
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accrued Expenses
    Change in Payable / Accrued Expenses
    Change in Other Liabilities
    Cash from Operating Activities6.348.456.09-0.6124.93
    Capital Expenditures-0.354-2.07-0.453-0.18-0.182
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.147-11.60.3470.238-4.52
    Acquisition of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-0.502-13.7-0.1060.058-4.71
    Financing Cash Flow Items-2.17-2.21-3.27-1.723.55
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-3.55-2.06-7.420.197-6.75
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash2.29-7.28-1.44-0.357-6.52